8 results match your criteria: "Cochrane Chile Associate Centre[Affiliation]"
Mental Health Services for Serious Mental Illness: Scoping Review of Randomised Controlled Trials.
Nurs Open
January 2025
Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
Aims: This review aims to classify the evidence from randomised controlled trials (RCTs) on mental health services (MHS) for people with serious mental illness (SMI) available in the Cochrane Schizophrenia Group's (CSzG) specialised register.
Design: Scoping review.
Methods: We retrieved and screened RCTs of service-level interventions considering non-pharmacological approaches for mental healthcare of the CSzG register.
Advocating for evidence-informed decisions to make healthcare fit for each person.
BMJ Evid Based Med
April 2022
Knowledge Translation Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Non-pharmacological interventions for autism spectrum disorder in children: an overview of systematic reviews.
BMJ Evid Based Med
August 2023
Associate Cochrane Centre - Research Department, Instituto Universitario del Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Article Synopsis
- The study evaluates the effectiveness of non-drug treatments for children with autism spectrum disorder (ASD) under 12 years old.
- A systematic review of existing studies was conducted, leading to the inclusion of four reliable reviews after filtering through 52 reports.
- Some interventions, like Early Intensive Behavioral Intervention and Applied Behavior Analysis, showed potential positive impacts on key areas such as language and social skills, though evidence quality varied.
Risperidone and aripiprazole for autism spectrum disorder in children: an overview of systematic reviews.
BMJ Evid Based Med
February 2023
Interdisciplinary Centre for Health Studies (CIESAL) - Cochrane Chile Associate Centre, Universidad de Valparaíso, Viña del Mar, Chile.
Objectives: To assess the effectiveness and safety of risperidone and aripiprazole in children with autism spectrum disorder (ASD).
Design And Setting: Overview of systematic reviews (SRs).
Search Methods: In October 2021, we searched Cochrane Central Register of Controlled Trials, MEDLINE, Embase, PsycInfo and Epistemonikos placing no restrictions on language or date of publication.
Stem cell therapy for dilated cardiomyopathy.
Cochrane Database Syst Rev
July 2021
Interdisciplinary Centre for Health Studies CIESAL, Universidad de Valparaíso, Viña del Mar, Chile.
Background: Stem cell therapy (SCT) has been proposed as an alternative treatment for dilated cardiomyopathy (DCM), nonetheless its effectiveness remains debatable.
Objectives: To assess the effectiveness and safety of SCT in adults with non-ischaemic DCM.
Search Methods: We searched CENTRAL in the Cochrane Library, MEDLINE, and Embase for relevant trials in November 2020.
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19.
BMJ Evid Based Med
June 2022
Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
Medwave
March 2021
Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre, Viña del Mar, Chile. Email: Address: Angamos 655 Reñaca, Viña del Mar, Chile. ORCID: 0000-0002-8095-5549.
Objective: This living systematic review aims to provide a timely, rigorous, and continuously updated summary of the evidence available on the role of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) in the treatment of patients with COVID-19.
Data Sources: We conducted searches in PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), grey literature and in a centralized repository in L·OVE (Living OVerview of Evidence), which retrieves articles from multiple sources such as PubMed/MEDLINE, Cochrane Central Register of Controlled Trials, Embase, among other pre-print and protocols repositories. In response to the COVID-19 emergency, L·OVE (Living OVerview of Evidence) was adapted to expand the range of evidence and customized to group all COVID-19 evidence in one place on a daily search basis.
Authors should also report the support for judgment when applying AMSTAR 2.
J Clin Epidemiol
October 2021
Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Cochrane Chile Associate Centre,Viña del Mar, Chile.